CSL has updated investors with a detailed presentation on the strategic rationale underpinning its recent acquisition of Vifor Pharma with the company anticipating its new division will deliver annual revenue growth above 10 per cent. …
Latest Video
New Stories
-
We now know what will be considered in March, but not what has been pushed to May
November 29, 2024 - - Latest News -
New data reveals how healthcare professionals can support communities to prepare for COVID-19
November 29, 2024 - - Latest News -
Stakeholders come together for consensus statement in support of 'bridging' fund
November 29, 2024 - - Latest News -
The Dispatched 'Week in Review' Podcast - 29 November
November 28, 2024 - - Podcast -
Senate backs order for the production of documents on submission deferrals
November 27, 2024 - - Latest News -
Outgoing President proposes dramatic expansion in funded access to anti-obesity therapies
November 27, 2024 - - Latest News -
Whooping cough cases surge across Australia as vaccination rates fall
November 27, 2024 - - Latest News